The very beginning of a pregnancy – the moment a developing embryo secures itself within the uterine lining – has long been a biological mystery. Now, scientists are achieving a remarkable feat: recreating this critical process, known as implantation, outside the human body. This isn’t simply observing cell division; it’s witnessing the intricate dialogue between a nascent embryo and the environment it needs to thrive.

Published this week in the journals Cell, three independent research teams – two from China and a collaborative effort spanning the United Kingdom, Spain, and the United States – have unveiled the most accurate laboratory models of early pregnancy to date. These models utilize human embryos sourced from in vitro fertilization (IVF) clinics, combined with meticulously engineered “organoids” that replicate the complex structure of the uterine lining, known as the endometrium.

“What we’re seeing is an embryo and an endometrial organoid working together,” explains Jun Wu, a biologist at the University of Texas Southwestern Medical Center, who contributed to the Chinese studies. “That’s the central finding across all three papers.” These 3D models promise to illuminate the reasons behind the frustratingly high failure rates often encountered in IVF treatments.

Ethical considerations dictate that experiments are halted after approximately two weeks of development, adhering to the widely accepted 14-day rule governing human embryo research. This limitation, however, doesn’t diminish the significance of the insights gained during this crucial early window.

The standard IVF process involves fertilizing an egg in a laboratory setting and allowing it to develop into a blastocyst – a spherical cluster of cells. This blastocyst is then transferred to the patient’s uterus, with the hope that it will successfully implant and develop into a viable pregnancy. But this implantation step is often the stumbling block. Many hopeful parents face the disappointment of a failed IVF cycle due to the embryo’s inability to attach to the uterine wall.

COURTESY OF THE RESEARCHERS

These new studies directly address this critical bottleneck, recreating the initial bond between mother and embryo in a controlled laboratory environment. “IVF has always been about in vitro fertilization,” notes Matteo Molè, a biologist at Stanford University involved in the European collaboration. “Now, we’re entering the era of in vitro implantation. If we can accurately model this process, we have the potential to significantly improve IVF success rates.”

Historically, studying human implantation has been incredibly challenging, as it occurs within the opaque environment of the uterus. Hongmei Wang, a developmental biologist at the Beijing Institute for Stem Cell and Regenerative Medicine, often relies on monkey models to observe the process, as pregnancies can be interrupted to collect necessary tissue samples. “We’ve always aspired to understand human embryo implantation, but lacked the tools to do so,” she explains. “It all happens inside the uterus, hidden from view.”

The Beijing team’s research involved approximately 50 donated IVF embryos, supplemented by over a thousand experiments utilizing “blastoids” – artificial embryos created from stem cells. Blastoids offer a significant advantage: they are easier to produce in large quantities and are subject to fewer ethical restrictions than true embryos. “The question was, what could we use these blastoids for?” asks Leqian Yu, the senior author of the Beijing Institute’s report. “Implantation was the logical next step.”

To achieve this, the Beijing researchers designed a soft silicone chamber with microchannels for nutrient delivery and a dedicated space for growing the uterine organoid. This allowed them to introduce blastoids – or actual embryos – into the system, effectively initiating a “pregnancy” within the chip. “Our primary goal is to understand the initial communication between the embryo and the mother,” says Yu. “This may be the first time we’ve been able to observe the entire process unfold.”

Medical Applications on the Horizon

Researchers aren’t the only ones recognizing the potential of organoid technology. Several startup companies, including Simbryo Technologies in Houston and Dawn Bio in Vienna, are actively commercializing similar systems, positioning them as tools for predicting IVF success. These companies offer a personalized approach: doctors take a biopsy of a patient’s uterine lining, grow organoids from the tissue, and then introduce blastoids to assess the likelihood of successful implantation. A failure of the blastoids to implant could indicate uterine receptivity issues, explaining previous IVF failures.

The Beijing team is also exploring the potential of these pregnancy organoids to identify drugs that could enhance implantation rates. They tested over 1,100 approved drugs on organoids created from tissue donated by women with recurrent IVF failures. Remarkably, several compounds showed promising results. Avobenzone, a common ingredient in sunscreen, increased blastoid implantation rates from 5% to 25%. Yu’s team is planning a clinical trial to further investigate this finding.

The Distant Prospect of an Artificial Womb

The Beijing group is continually refining their organoid system, aiming for greater realism. Currently, it lacks crucial components like immune cells and a functional blood supply. Yu’s team is working on integrating blood vessels and miniature pumps into the chip, providing the organoids with a rudimentary circulatory system. This advancement could allow for the extended cultivation of blastoids or embryos, raising profound questions about the future of pregnancy research.

“This technology certainly opens the door to growing embryos for longer periods,” says Wu, acknowledging that some view this research as a stepping stone towards creating entirely artificial wombs. However, he emphasizes that achieving a full-term pregnancy in a laboratory setting remains firmly in the realm of science fiction. “This is related to ectogenesis – development outside the body – but we are nowhere near an artificial womb at this point.”

What are the ethical implications of extending embryo development outside the body, and how should society navigate these complex issues? And considering the potential for personalized IVF treatments based on organoid technology, how might this reshape the landscape of reproductive medicine?

Frequently Asked Questions About Lab-Grown Implantation Models